Summary

Persistence Market Research has recently published a detailed report on the North American Quadriplegia Care Devices market. This report provides an in-depth analysis of market dynamics, including key drivers, trends, opportunities, and challenges, offering a comprehensive overview of the market structure.

Key Insights:

• Quadriplegia Care Devices Market Size (2024E): USD 623.9 Mn
• Projected Market Value (2031F): USD 813.6 Mn
• North American Market Growth Rate (CAGR 2024 to 2031): 3.0%

Quadriplegia Care Devices Market - Report Scope:

Quadriplegia care devices are crucial for enhancing the quality of life for individuals with quadriplegia by supporting and improving daily activities. This market includes various assistive technologies such as wheelchairs, robotic exoskeletons, and communication aids. The North American market is propelled by advancements in technology, a rising incidence of quadriplegia from accidents and medical conditions, and growing awareness regarding enhanced care solutions.

Market Growth Drivers:

Several factors are driving the growth of the North American quadriplegia care devices market, including an increasing number of spinal cord injuries and neurological disorders leading to quadriplegia. Technological advancements in assistive devices—such as improved robotic exoskeletons and smart wheelchairs—contribute to market growth by providing better functionality and comfort. Increased funding for research and development, along with government initiatives and healthcare reforms focusing on disability care, support market expansion. Additionally, the aging population with mobility issues is fueling demand for innovative care solutions.

Market Restraints:

Despite the market’s potential, challenges include the high costs associated with advanced technologies and the complexity of integrating new devices into existing care systems. The high expense of cutting-edge devices can be a significant barrier for patients and healthcare providers, particularly in areas with constrained healthcare budgets. The ongoing maintenance and updates required for these devices also impact the total cost of ownership. Regulatory hurdles and stringent healthcare standards further complicate market participation.

Market Opportunities:

The North American quadriplegia care devices market offers substantial growth opportunities through technological advancements and increasing demand for personalized care solutions. Innovations in telemedicine and remote monitoring technologies create new possibilities for effective quadriplegia management. Expanding partnerships with healthcare providers, investing in R&D for new functionalities, and exploring emerging markets within North America are key growth strategies. The development of cost-effective and user-friendly solutions will also be essential in capturing a larger market share.

Key Questions Answered in the Report:

• What are the primary factors driving growth in the North American quadriplegia care devices market?
• Which types of quadriplegia care devices are seeing the highest adoption in the region?
• How are technological advancements shaping the competitive landscape of the quadriplegia care devices market?
• Who are the leading players in the North American quadriplegia care devices market, and what strategies are they using to maintain their competitive edge?
• What are the emerging trends and future prospects in the North American quadriplegia care devices market?

Competitive Intelligence and Business Strategy:

Key players in the North American quadriplegia care devices market, including Invacare Corporation, ReWalk Robotics, and Otto Bock Healthcare, are emphasizing innovation, strategic partnerships, and market expansion to maintain their competitive edge. These companies are investing in R&D to develop advanced care solutions, such as next-generation wheelchairs and exoskeletons, to meet the diverse needs of patients. Collaborations with healthcare providers and research institutions facilitate market access and technology adoption. Focusing on product reliability, patient comfort, and cutting-edge technology is crucial for reinforcing the position of leading players in this evolving market.

Key Companies Profiled:

• ReWalk Robotics
• Ekso Bionics
• Indego (Parker Hannifin Corporation)
• Rex Bionics Ltd.
• Caltech
• Össur
• Steeper, Inc.
• Boston Scientific Corporation
• Medtronic Plc.
• Ottobock
• RGK Wheelchairs
• Rifton Equipment
• Allard USA, Inc.
• Fillauer LLC
• College Park Industries
• Mobius Bionics
• Parker Hannifin
• Nevro
• ProBed Medical Technologies Inc.
• BLUE CHIP MEDICAL
• Restorative Therapies
• MYOLYN, LLC

Key Segments in North American Quadriplegia Care Devices Market

By Product:

• Stimulation Devices
• Assistive Devices
• Mobility Devices
• Hospital Beds
• Transfer Bench and Boards
• Braces & Supports
• Orthopaedic Splints
• Other Supportive Devices

By Indication:

• Incomplete Quadriplegia
• Complete Quadriplegia

By End User:

• Rehabilitation Centres
• Assistive Living Facilities
• Long-term Care Centers
• Home Care Settings

By Country:

• U.S. Quadriplegia Care Devices Market
• Canada Quadriplegia Care Devices Market

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. North America Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion & Exclusion
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Trends in Diverse Applications
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Increasing government support for the medical device sector
4.1.2. Improved economic conditions leading to increased penetration by companies
4.1.3. Rise in R&D spending
4.2. Forecast Factors - Relevance & Impact
4.2.1. Product Launches
4.2.2. R&D expenditure by key players
4.2.3. Degree of Technology advancements
4.2.4. Adoption Rate
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
5. Market Context
5.1. Emerging Technologies for Support & Care
5.2. Regulatory Scenario
5.3. PESTLE Analysis
5.4. PORTERS Analysis
5.5. Key Manufacturer’s Promotional Strategies
6. COVID19 Crisis Analysis
6.1. Current GDP Projection and Probable Impact
6.2. Current Economic Projection as compared to 2008 financial analysis
6.3. COVID19 and Impact Analysis
6.3.1. Revenue by Products
6.3.2. Revenue by Indication
6.3.3. Revenue by End User
6.3.4. Revenue by Country
6.4. 2024 Market Scenario
7. North America Quadriplegia Care Devices Market Demand (in Units) Analysis 2019-2023 and Forecast, 2024-2031
7.1. Historical Market Volume (in Units) Analysis, 2019-2023
7.2. Current and Future Market Volume (in Units) Projections, 2024-2031
7.2.1. Y-o-Y Growth Trend Analysis
8. Quadriplegia Care Devices Market -Pricing Analysis
8.1. Regional Pricing Analysis by Indication
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Average Pricing Analysis Benchmark
9. North America Quadriplegia Care Devices Market Value (US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031
9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. North America Quadriplegia Care Devices Market Analysis 2019-2023 and Forecast 2024-2031, by Products
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis and Volume in Units) By Products, 2019-2023
10.3. Current and Future Market Size (US$ Mn) and Volume in Units) Analysis and Forecast by Products, 2024-2031
10.3.1. Stimulation Devices
10.3.1.1. Spinal cord Stimulators
10.3.1.2. Functional Electrical Stimulation (FES) Systems
10.3.2. Assistive Devices
10.3.2.1. Exoskeletons
10.3.2.2. Robotic Arm Systems
10.3.2.3. Prosthetics
10.3.2.3.1. Upper Limb Prosthetics
10.3.2.3.2. Lower Limb Prosthetics
10.3.3. Mobility Devices
10.3.3.1. Wheelchairs
10.3.3.2. Crutches & Walkers
10.3.3.3. Gait Trainers
10.3.4. Hospital Beds
10.3.5. Transfer Bench and Boards
10.3.6. Braces & Supports
10.3.7. Orthopaedic Splints
10.3.8. Others Supportive Devices
10.4. Market Attractiveness Analysis by Products
11. North America Quadriplegia Care Devices Market Analysis 2019-2023 and Forecast 2024-2031, by Indication
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis by Indication, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Indication, 2024-2031
11.3.1. Incomplete quadriplegia
11.3.2. Complete quadriplegia
11.4. Market Attractiveness Analysis by Indication
12. North America Quadriplegia Care Devices Market Analysis 2019-2023 and Forecast 2024-2031, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2031
12.3.1. Hospitals
12.3.2. Rehabilitation Centres
12.3.3. Assistive Living Facilities
12.3.4. Long Term Care Centres
12.3.5. Home Care Settings
12.4. Market Attractiveness Analysis by End User
13. US Quadriplegia Care Devices Market Analysis 2019-2023 and Forecast 2024-2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
13.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2031
13.3.1. By Products
13.3.2. By Indication
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Canada Quadriplegia Care Devices Market Analysis 2019-2023 and Forecast 2024-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
14.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2031
14.3.1. By Products
14.3.2. By Indication
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Competition Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Competition Deep Dive
15.3.1. ReWalk Robotics
15.3.1.1. Overview
15.3.1.2. Product Portfolio
15.3.1.3. Key Financials
15.3.1.4. Recent Developments
15.3.1.5. Sales Footprint
15.3.1.6. Strategy Overview
15.3.1.6.1. Marketing Strategy
15.3.1.6.2. Product Strategy
15.3.1.6.3. Channel Strategy
15.3.2. Ekso Bionics
15.3.2.1. Overview
15.3.2.2. Product Portfolio
15.3.2.3. Key Financials
15.3.2.4. Recent Developments
15.3.2.5. Sales Footprint
15.3.2.6. Strategy Overview
15.3.2.6.1. Marketing Strategy
15.3.2.6.2. Product Strategy
15.3.2.6.3. Channel Strategy
15.3.3. Indego (Parker Hannifin Corporation)
15.3.3.1. Overview
15.3.3.2. Product Portfolio
15.3.3.3. Key Financials
15.3.3.4. Recent Developments
15.3.3.5. Sales Footprint
15.3.3.6. Strategy Overview
15.3.3.6.1. Marketing Strategy
15.3.3.6.2. Product Strategy
15.3.3.6.3. Channel Strategy
15.3.4. Rex Bionics Ltd.
15.3.4.1. Overview
15.3.4.2. Product Portfolio
15.3.4.3. Key Financials
15.3.4.4. Recent Developments
15.3.4.5. Sales Footprint
15.3.4.6. Strategy Overview
15.3.4.6.1. Marketing Strategy
15.3.4.6.2. Product Strategy
15.3.4.6.3. Channel Strategy
15.3.5. Caltech
15.3.5.1. Overview
15.3.5.2. Product Portfolio
15.3.5.3. Key Financials
15.3.5.4. Recent Developments
15.3.5.5. Sales Footprint
15.3.5.6. Strategy Overview
15.3.5.6.1. Marketing Strategy
15.3.5.6.2. Product Strategy
15.3.5.6.3. Channel Strategy
15.3.6. Össur
15.3.6.1. Overview
15.3.6.2. Product Portfolio
15.3.6.3. Key Financials
15.3.6.4. Recent Developments
15.3.6.5. Sales Footprint
15.3.6.6. Strategy Overview
15.3.6.6.1. Marketing Strategy
15.3.6.6.2. Product Strategy
15.3.6.6.3. Channel Strategy
15.3.7. Steeper, Inc.
15.3.7.1. Overview
15.3.7.2. Product Portfolio
15.3.7.3. Key Financials
15.3.7.4. Recent Developments
15.3.7.5. Sales Footprint
15.3.7.6. Strategy Overview
15.3.7.6.1. Marketing Strategy
15.3.7.6.2. Product Strategy
15.3.7.6.3. Channel Strategy
15.3.8. Boston Scientific corporation
15.3.8.1. Overview
15.3.8.2. Product Portfolio
15.3.8.3. Key Financials
15.3.8.4. Recent Developments
15.3.8.5. Sales Footprint
15.3.8.6. Strategy Overview
15.3.8.6.1. Marketing Strategy
15.3.8.6.2. Product Strategy
15.3.8.6.3. Channel Strategy
15.3.9. Medtronic Plc.
15.3.9.1. Overview
15.3.9.2. Product Portfolio
15.3.9.3. Key Financials
15.3.9.4. Recent Developments
15.3.9.5. Sales Footprint
15.3.9.6. Strategy Overview
15.3.9.6.1. Marketing Strategy
15.3.9.6.2. Product Strategy
15.3.9.6.3. Channel Strategy
15.3.10. Ottobock
15.3.10.1. Overview
15.3.10.2. Product Portfolio
15.3.10.3. Key Financials
15.3.10.4. Recent Developments
15.3.10.5. Sales Footprint
15.3.10.6. Strategy Overview
15.3.10.6.1. Marketing Strategy
15.3.10.6.2. Product Strategy
15.3.10.6.3. Channel Strategy
15.3.11. RGK Wheelchairs
15.3.11.1. Overview
15.3.11.2. Product Portfolio
15.3.11.3. Key Financials
15.3.11.4. Recent Developments
15.3.11.5. Sales Footprint
15.3.11.6. Strategy Overview
15.3.11.6.1. Marketing Strategy
15.3.11.6.2. Product Strategy
15.3.11.6.3. Channel Strategy
15.3.12. Rifton Equipment
15.3.12.1. Overview
15.3.12.2. Product Portfolio
15.3.12.3. Key Financials
15.3.12.4. Recent Developments
15.3.12.5. Sales Footprint
15.3.12.6. Strategy Overview
15.3.12.6.1. Marketing Strategy
15.3.12.6.2. Product Strategy
15.3.12.6.3. Channel Strategy
15.3.13. Allard USA, Inc.
15.3.13.1. Overview
15.3.13.2. Product Portfolio
15.3.13.3. Key Financials
15.3.13.4. Recent Developments
15.3.13.5. Sales Footprint
15.3.13.6. Strategy Overview
15.3.13.6.1. Marketing Strategy
15.3.13.6.2. Product Strategy
15.3.13.6.3. Channel Strategy
15.3.14. Fillauer LLC
15.3.14.1. Overview
15.3.14.2. Product Portfolio
15.3.14.3. Key Financials
15.3.14.4. Recent Developments
15.3.14.5. Sales Footprint
15.3.14.6. Strategy Overview
15.3.14.6.1. Marketing Strategy
15.3.14.6.2. Product Strategy
15.3.14.6.3. Channel Strategy
15.3.15. College Park Industries
15.3.15.1. Overview
15.3.15.2. Product Portfolio
15.3.15.3. Key Financials
15.3.15.4. Recent Developments
15.3.15.5. Sales Footprint
15.3.15.6. Strategy Overview
15.3.15.6.1. Marketing Strategy
15.3.15.6.2. Product Strategy
15.3.15.6.3. Channel Strategy
15.3.16. Mobius Bionics.
15.3.16.1. Overview
15.3.16.2. Product Portfolio
15.3.16.3. Key Financials
15.3.16.4. Recent Developments
15.3.16.5. Sales Footprint
15.3.16.6. Strategy Overview
15.3.16.6.1. Marketing Strategy
15.3.16.6.2. Product Strategy
15.3.16.6.3. Channel Strategy
15.3.17. Parker Hannifin
15.3.17.1. Overview
15.3.17.2. Product Portfolio
15.3.17.3. Key Financials
15.3.17.4. Recent Developments
15.3.17.5. Sales Footprint
15.3.17.6. Strategy Overview
15.3.17.6.1. Marketing Strategy
15.3.17.6.2. Product Strategy
15.3.17.6.3. Channel Strategy
15.3.18. Nevro
15.3.18.1. Overview
15.3.18.2. Product Portfolio
15.3.18.3. Key Financials
15.3.18.4. Recent Developments
15.3.18.5. Sales Footprint
15.3.18.6. Strategy Overview
15.3.18.6.1. Marketing Strategy
15.3.18.6.2. Product Strategy
15.3.18.6.3. Channel Strategy
15.3.19. ProBed Medical Technologies Inc.
15.3.19.1. Overview
15.3.19.2. Product Portfolio
15.3.19.3. Key Financials
15.3.19.4. Recent Developments
15.3.19.5. Sales Footprint
15.3.19.6. Strategy Overview
15.3.19.6.1. Marketing Strategy
15.3.19.6.2. Product Strategy
15.3.19.6.3. Channel Strategy
15.3.20. BLUE CHIP MEDICAL
15.3.20.1. Overview
15.3.20.2. Product Portfolio
15.3.20.3. Key Financials
15.3.20.4. Recent Developments
15.3.20.5. Sales Footprint
15.3.20.6. Strategy Overview
15.3.20.6.1. Marketing Strategy
15.3.20.6.2. Product Strategy
15.3.20.6.3. Channel Strategy
15.3.21. Restorative Therapies
15.3.21.1. Overview
15.3.21.2. Product Portfolio
15.3.21.3. Key Financials
15.3.21.4. Recent Developments
15.3.21.5. Sales Footprint
15.3.21.6. Strategy Overview
15.3.21.6.1. Marketing Strategy
15.3.21.6.2. Product Strategy
15.3.21.6.3. Channel Strategy
15.3.22. MYOLYN, LLC
15.3.22.1. Overview
15.3.22.2. Product Portfolio
15.3.22.3. Key Financials
15.3.22.4. Recent Developments
15.3.22.5. Sales Footprint
15.3.22.6. Strategy Overview
15.3.22.6.1. Marketing Strategy
15.3.22.6.2. Product Strategy
15.3.22.6.3. Channel Strategy
16. Assumptions and Acronyms Used
17. Research Methodology